Work

Biological and clinical effects of abemaciclib in a phase 2 neoadjuvant study for postmenopausal patients with HR+/HER2- breast cancer

Year: 2017

Type: article

Source: Annals of Oncology

DOI: 10.1093/annonc/mdx424.002

Authors: V. Guarneri, P.A. Fasching, M. Fernández Abad, J.A. García-Saenz, A. Schneeweiss, M. Colleoni, E. Petru, T.M. Costigan, C.W. Caldwell, S. Barriga, S. Hurvitz, D. Slamon

Institutions: University of Padua, Universitätsklinikum Erlangen, Hospital Universitario Ramón y Cajal, Hospital Clínico San Carlos, National Center for Tumor Diseases, European Institute of Oncology, Medical University of Graz, Eli Lilly (United States), University of California, Los Angeles

Language: English

Topic: Advanced Breast Cancer Therapies

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2767485771

FWCI: 0.681

Cites:

Cited by: 4

Related to: 10